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The importance of the CD40-CD40-ligand interaction is underscored by the X-linked hyper-IgM syndrome. Affected males with this primary immunodeficiency disorder cannot produce IgG and thus cannot mount an effective immune response to antigens (3) . As a consequence, these patients have recurrent opportunistic infections. This syndrome results from a mutation( s) in the gene encoding the CD40-ligand on the X chromosome, making it impossible for activated T cells to effect CD40-crosslinking (for review see reference 2).
In this issue of The Journal, Hollenbaugh et al. (4) describe their studies on female carriers of the X-linked hyper-IgM syndrome. Because of X-inactivation (5) , they find that the activated T cells of such carriers express either the normal gene or an allele encoding a defective CD40-ligand. Importantly, they detect cases of extreme Lyonization. While the activated T cells of some carriers are difficult to distinguish from those of normal donors, most of the activated T cells of other carriers are found to express only the defective CD40-ligand. By all other parameters tested, however, these and other carriers of the X-linked hyper-IgM syndrome have a fully competent immune system.
In many immunologic intercellular interactions, there is a reciprocal dialogue. A recent report indicates that T cells can receive a co-stimulatory signal from CD40-expressing cells via the CD40-ligand (6) . However, the physiologic significance of this co-stimulatory signal is not clear. Patients with the X-linked hyper-IgM syndrome have normal numbers of T cells, suggesting that expression of a functional CD40-ligand is not necessary for T cell maturation and survival. The study by Hollenbaugh et al. (4) goes one step further, suggesting that T cells capable of expressing only a defective CD40-ligand can compete effectively with normal T cells for maturation and egress from the thymus. Still unexplained, however, is a prior study, indicating there may in fact be preferential inactivation of the normal paternally derived X chromosome in obligate carriers of this disease (7). While this noted bias may be due to sample variation, if found true, it would suggest that there may be a differentiation and/or proliferation advantage to hematopoietic precursors expressing the X chromosome with the defective allele. In any case, this is very unlike other X-linked immune deficiencies, such as X-linked agammaglobulinemia or X-linked severe 
